VNRX Competitors & Alternatives
Compare VolitionRX Limited Common Stock with similar stocks in the same industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
VNRX
Main Stock$0.19
Tradestie Score
52
Market Cap
$66.94M
Revenue Growth
0.3%
Analyst Upside
+997.8%
Top Competitors
19 stocks in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
$563.48
|
$49.61B | 43.9 | 59 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$74.19
|
$3.51B | 22.4 | 57 | Compare |
|
QDEL
QuidelOrtho Corporation Common Stock
|
$15.13
|
$2.12B | - | 41 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.02
|
$2.01B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$29.99
|
$1.68B | - | 54 | Compare |
|
NNNN
Anbio Biotechnology Class A Ordinary Shares
|
$24.00
|
$1.53B | 386.7 | 51 | Compare |
|
NEOG
Neogen Corp
|
$8.90
|
$1.26B | - | 53 | Compare |
|
MYGN
Myriad Genetics Inc
|
$4.35
|
$719.23M | - | 52 | Compare |
|
TKNO
Alpha Teknova, Inc. Common Stock
|
$2.76
|
$340.89M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$2.72
|
$158.43M | - | 45 | Compare |
More VNRX Analysis
Data updated: Mar 30, 2026 | Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES (SIC 2835)
19 stocks in this industry